Publications by Arian Lundberg
Peer reviewed
Articles
[1]
R. Shrestha et al., "An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor Progression," Cancer Research, vol. 84, no. 18, pp. 3086-3100, 2024.
[2]
L. N. Chesner et al., "Androgen receptor inhibition increases MHC Class I expression and improves immune response in prostate cancer," Cancer Discovery, vol. 15, no. 3, pp. 481-494, 2024.
[3]
D. Westaby et al., "BCL2 expression is enriched in advanced prostate cancer with features of lineage plasticity," Journal of Clinical Investigation, vol. 134, no. 18, 2024.
[4]
G. Seed et al., "Elucidating acquired PARP inhibitor resistance in advanced prostate cancer," Cancer Cell, vol. 42, no. 12, pp. 2113-2123.e4, 2024.
[5]
S. G. Zhao et al., "Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer," Nature Genetics, vol. 56, no. 8, pp. 1689-1700, 2024.
[6]
M. Zhang et al., "Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progression," Nature Cell Biology, vol. 26, no. 7, pp. 1176-1186, 2024.
[7]
A. Lundberg et al., "The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer," Cancer Research, vol. 83, no. 16, pp. 2763-2774, 2023.
[8]
E. Feng et al., "Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate Cancer," Clinical Cancer Research, vol. 28, no. 24, pp. 5396-5404, 2022.
[9]
A. Lundberg et al., "Reclassifying tumour cell cycle activity in terms of its tissue of origin," npj Precision Oncology, vol. 6, no. 1, 2022.
[10]
M. Sjöström et al., "The 5-Hydroxymethylcytosine Landscape of Prostate Cancer," Cancer Research, vol. 82, no. 21, pp. 3888-3902, 2022.
[11]
A. Lundberg, B. Li and R. Li, "B cell-related gene signature and cancer immunotherapy response," British Journal of Cancer, vol. 126, no. 6, pp. 899-906, 2021.
[12]
A. Lundberg et al., "A pan-cancer analysis of the frequency of DNA alterations across cell cycle activity levels," Oncogene, vol. 39, no. 32, pp. 5430-5440, 2020.
[13]
A. Lundberg et al., "The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours," Breast Cancer Research, vol. 21, no. 1, 2019.
[14]
A. Lundberg et al., "Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer Cohorts," Clinical Cancer Research, vol. 23, no. 24, pp. 7512-7520, 2017.
[15]
N. P. Tobin et al., "PAM50 Provides Prognostic Information When Applied to the Lymph Node Metastases of Advanced Breast Cancer Patients," Clinical Cancer Research, vol. 23, no. 23, pp. 7225-7231, 2017.
Latest sync with DiVA:
2025-09-14 02:15:10 UTC